Neuroprotective effect of G<sup>14</sup>-humanin on global cerebral ischemia/reperfusion by activation of SOCS3 - STAT3 - MCL-1 signal transduction pathway in rats.
Gao. Guangsheng G; Fan. Huaihai H; Zhang. Xiaoying X; Zhang. Fusen F; Wu. Haiyan H; Qi. Feng F; Zhao. Lei L; Li. Yun Y
Key Findings
- HNG reduced neuronal loss in the hippocampus after global cerebral ischemia/reperfusion in rats
- HNG lowered pro‑apoptotic proteins Bax and Caspase‑3 compared to untreated injured rats
- HNG increased activation of the SOCS3‑STAT3‑MCL‑1 pathway, which is linked to cell survival
Practical Outcomes
- The study shows that a humanin variant can protect brain cells in an animal stroke model, hinting at possible neuroprotective uses for humans. However, no human dosing or safety data are provided, so biohackers should view this as early‑stage research rather than a ready‑to‑use protocol.
Summary
In rats that suffered a brief loss of blood flow to the brain, giving them a special form of the peptide humanin (called G14‑humanin or HNG) helped protect brain cells from dying. The peptide lowered markers of cell death and boosted a protective signaling pathway (SOCS3‑STAT3‑MCL‑1).
Abstract
Humanin (HN) has been identified to suppress neuron death. Gly<sup>14</sup>-HN (HNG), as a variant of HN, can decrease infarct volume after ischemia/reperfusion (I/R) injury. This study aimed to investigate the neuroprotective mechanism of HNG on global cerebral I/R (GI) in rats. Rats were randomly divided into 13 groups: Sham group, GI groups and HNG groups. Both GI group and HNG groups included six time points (1, 3, 6, 12, 24, and 72 h). At 24 h after reperfusion, Nissl staining was used to observe positive neurons, and p-STAT3, MCL-1, SOCS3, Bax and Caspase-3 in different groups were detected by immunohistochemistry. qRT-PCR and western blot were used to evaluate the expression of STAT3, p-STAT3, MCL-1, and SOCS3. The immunohistochemistry also showed a significant increase in Bax (0.29 ± 0.007 vs. 0.22 ± 0.007, P < 0.01) and Caspase-3 (0.24 ± 0.02 vs. 0.18 ± 0.006, P < 0.01) in GI group compared with Sham group, while Bax (0.26 ± 0.01 vs. 0.29 ± 0.008, P < 0.01) and Caspase-3 (0.20 ± 0.008 vs. 0.24 ± 0.02, P < 0.01) were significantly decreased by HNG-treatment compared with GI group. Along with immunohistochemistry, western blot and qRT-PCR indicated that the protein and mRNA levels of STAT3, MCL-1, and SOCS3 were up-regulated after administration of HNG at six time points after global cerebral I/R in rat. HNG might exert neuroprotective effects through alleviating apoptosis and activating of SOCS3 - STAT3 - MCL-1 signal transduction pathway. Highlights (1) Cerebral ischemia led to neuronal loss in hippocampal CA1 region of rats. (2) HNG had neuroprotective effects on ischemia/reperfusion rats. (3) The protective effect of HNG might be related to the SOCS3 - STAT3 - MCL-1 pathway.
Study Information
pubmed
2017
2017-07-18T00:00:00.000Z
10.1080/01616412.2017.1352187
16
35